|
1
|
Mizushima N: Autophagy: Process and
function. Genes Dev. 21:2861–2873. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Mizushima N, Yoshimori T and Ohsumi Y: The
role of Atg proteins in autophagosome formation. Annu Rev Cell Dev
Biol. 27:107–132. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Klionsky DJ: Autophagy: From phenomenology
to molecular understanding in less than a decade. Nat Rev Mol Cell
Biol. 8:931–937. 2007. View
Article : Google Scholar : PubMed/NCBI
|
|
4
|
Galluzzi L, Pietrocola F, Bravo-San Pedro
JM, Amaravadi RK, Baehrecke EH, Cecconi F, Codogno P, Debnath J,
Gewirtz DA, Karantza V, et al: Autophagy in malignant
transformation and cancer progression. EMBO J. 34:856–880. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Amaravadi R, Kimmelman AC and White E:
Recent insights into the function of autophagy in cancer. Genes
Dev. 30:1913–1930. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Levy JM and Thorburn A: Targeting
autophagy during cancer therapy to improve clinical outcomes.
Pharmacol Ther. 131:130–141. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Towers CG and Thorburn A: Therapeutic
targeting of autophagy. EBioMedicine. 14:15–23. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Jing Z, Han W, Sui X, Xie J and Pan H:
Interaction of autophagy with microRNAs and their potential
therapeutic implications in human cancers. Cancer Lett.
356B:332–338. 2015. View Article : Google Scholar
|
|
9
|
Fu LL, Wen X, Bao JK and Liu B:
MicroRNA-modulated autophagic signaling networks in cancer. Int J
Biochem Cell Biol. 44:733–736. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Xu J, Wang Y, Tan X and Jing H: MicroRNAs
in autophagy and their emerging roles in crosstalk with apoptosis.
Autophagy. 8:873–882. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Iorio MV and Croce CM: MicroRNAs in
cancer: Small molecules with a huge impact. J Clin Oncol.
27:5848–5856. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Bartel DP: MicroRNAs: Genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Huang Y, Chuang AY and Ratovitski EA:
Phospho-∆Np63α/miR-885-3p axis in tumor cell life and cell death
upon cisplatin exposure. Cell Cycle. 10:3938–3947. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zhu H, Wu H, Liu X, Li B, Chen Y, Ren X,
Liu CG and Yang JM: Regulation of autophagy by a Beclin 1-targeted
microRNA, miR-30a, in cancer cells. Autophagy. 5:816–823. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Chang Y, Yan W, He X, Zhang L, Li C, Huang
H, Nace G, Geller DA, Lin J and Tsung A: miR-375 inhibits autophagy
and reduces viability of hepatocellular carcinoma cells under
hypoxic conditions. Gastroenterology. 143:177–187.e8. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Korkmaz G, le Sage C, Tekirdag KA, Agami R
and Gozuacik D: miR-376b controls starvation and mTOR
inhibition-related autophagy by targeting ATG4C and BECN1.
Autophagy. 8:165–176. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Tekirdag KA, Korkmaz G, Ozturk DG, Agami R
and Gozuacik D: MIR181A regulates starvation- and rapamycin-induced
autophagy through targeting of ATG5. Autophagy. 9:374–385. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Ren Y, Chen Y, Liang X, Lu Y, Pan W and
Yang M: miRNA-638 promotes autophagy and malignant phenotypes of
cancer cells via directly suppressing DACT3. Cancer Lett.
390:126–136. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Guo W, Wang H, Yang Y, Guo S, Zhang W, Liu
Y, Yi X, Ma J, Zhao T, Liu L, et al: Down-regulated miR-23a
contributes to the metastasis of cutaneous melanoma by promoting
autophagy. Theranostics. 7:2231–2249. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Wang Y, Zhang X, Tang W, Lin Z, Xu L, Dong
R, Li Y, Li J, Zhang Z, Li X, et al: miR-130a upregulates mTOR
pathway by targeting TSC1 and is transactivated by NF-κB in
high-grade serous ovarian carcinoma. Cell Death Differ.
24:2089–2100. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Du X, Huo X, Yang Y, Hu Z, Botchway BOA,
Jiang Y and Fang M: miR-124 downregulates BACE 1 and alters
autophagy in APP/PS1 transgenic mice. Toxicol Lett. 280:195–205.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Triozzi PL, Achberger S, Aldrich W, Crabb
JW, Y and Singh AD: Association of tumor and plasma microRNA
expression with tumor monosomy-3 in patients with uveal melanoma.
Clin Epigenetics. 8:802016. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Zhou Z, Wang Z, Wei H, Wu S, Wang X and
Xiao J: Promotion of tumour proliferation, migration and invasion
by miR-92b in targeting RECK in osteosarcoma. Clin Sci (Lond).
130:921–930. 2016. View Article : Google Scholar
|
|
24
|
Huang J, Wang B, Hui K, Zeng J, Fan J,
Wang X, Hsieh JT, He D and Wu K: miR-92b targets DAB2IP to promote
EMT in bladder cancer migration and invasion. Oncol Rep.
36:1693–1701. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Zhao C, Zhao F, Feng H, Xu S and Qin G:
MicroRNA-92b inhibits epithelial-mesenchymal transition-induced
migration and invasion by targeting Smad3 in nasopharyngeal cancer.
Oncotarget. 8:91603–91613. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
27
|
Nowakowski TJ, Fotaki V, Pollock A, Sun T,
Pratt T and Price DJ: MicroRNA-92b regulates the development of
intermediate cortical progenitors in embryonic mouse brain. Proc
Natl Acad Sci USA. 110:7056–7061. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Zhou X, Zhu W, Li H, Wen W, Cheng W, Wang
F, Wu Y, Qi L, Fan Y, Chen Y, et al: Diagnostic value of a plasma
microRNA signature in gastric cancer: A microRNA expression
analysis. Sci Rep. 5:112512015. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Wu ZB, Cai L, Lin SJ, Lu JL, Yao Y and
Zhou LF: The miR-92b functions as a potential oncogene by targeting
on Smad3 in glioblastomas. Brain Res. 1529:16–25. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Li Y, Li L, Guan Y, Liu X, Meng Q and Guo
Q: miR-92b regulates the cell growth, cisplatin chemosensitivity of
A549 non small cell lung cancer cell line and target PTEN. Biochem
Biophys Res Commun. 440:604–610. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Ma G, Jing C, Li L, Huang F, Ding F, Wang
B, Lin D, Luo A and Liu Z: MicroRNA-92b represses
invasion-metastasis cascade of esophageal squamous cell carcinoma.
Oncotarget. 7:20209–20222. 2016.PubMed/NCBI
|
|
32
|
Ma G, Jing C, Huang F, Li X, Cao X and Liu
Z: Integrin α6 promotes esophageal cancer metastasis and is
targeted by miR-92b. Oncotarget. 8:6681–6690. 2017.
|
|
33
|
Vidigal JA and Ventura A: The biological
functions of miRNAs: Lessons from in vivo studies. Trends Cell
Biol. 25:137–147. 2015. View Article : Google Scholar :
|
|
34
|
Müller J, Hart CM, Francis NJ, Vargas ML,
Sengupta A, Wild B, Miller EL, O'Connor MB, Kingston RE and Simon
JA: Histone methyltransferase activity of a Drosophila Polycomb
group repressor complex. Cell. 111:197–208. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Czermin B, Melfi R, McCabe D, Seitz V,
Imhof A and Pirrotta V: Drosophila enhancer of Zeste/ESC complexes
have a histone H3 methyltransferase activity that marks chromosomal
Polycomb sites. Cell. 111:185–196. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Varambally S, Dhanasekaran SM, Zhou M,
Barrette TR, Kumar-Sinha C, Sanda MG, Ghosh D, Pienta KJ, Sewalt
RG, Otte AP, et al: The polycomb group protein EZH2 is involved in
progression of prostate cancer. Nature. 419:624–629. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Kleer CG, Cao Q, Varambally S, Shen R, Ota
I, Tomlins SA, Ghosh D, Sewalt RG, Otte AP, Hayes DF, et al: EZH2
is a marker of aggressive breast cancer and promotes neoplastic
transformation of breast epithelial cells. Proc Natl Acad Sci USA.
100:11606–11611. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Collett K, Eide GE, Arnes J, Stefansson
IM, Eide J, Braaten A, Aas T, Otte AP and Akslen LA: Expression of
enhancer of zeste homologue 2 is significantly associated with
increased tumor cell proliferation and is a marker of aggressive
breast cancer. Clin Cancer Res. 12:1168–1174. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Liu F, Gu L, Cao Y, Fan X, Zhang F and
Sang M: Aberrant overexpression of EZH2 and H3K27me3 serves as poor
prognostic biomarker for esophageal squamous cell carcinoma
patients. Biomarkers. 21:80–90. 2016. View Article : Google Scholar
|
|
40
|
Wei FZ, Cao Z, Wang X, Wang H, Cai MY, Li
T, Hattori N, Wang D, Du Y, Song B, et al: Epigenetic regulation of
autophagy by the methyltransferase EZH2 through an MTOR-dependent
pathway. Autophagy. 11:2309–2322. 2015. View Article : Google Scholar
|
|
41
|
Schlesinger Y, Straussman R, Keshet I,
Farkash S, Hecht M, Zimmerman J, Eden E, Yakhini Z, Ben-Shushan E,
Reubinoff BE, et al: Polycomb-mediated methylation on Lys27 of
histone H3 pre-marks genes for de novo methylation in cancer. Nat
Genet. 39:232–236. 2007. View
Article : Google Scholar : PubMed/NCBI
|
|
42
|
Tonini T, D'Andrilli G, Fucito A, Gaspa L
and Bagella L: Importance of Ezh2 polycomb protein in tumorigenesis
process interfering with the pathway of growth suppressive key
elements. J Cell Physiol. 214:295–300. 2008. View Article : Google Scholar
|
|
43
|
Widschwendter M, Fiegl H, Egle D,
Mueller-Holzner E, Spizzo G, Marth C, Weisenberger DJ, Campan M,
Young J, Jacobs I, et al: Epigenetic stem cell signature in cancer.
Nat Genet. 39:157–158. 2007. View
Article : Google Scholar : PubMed/NCBI
|
